Depending on whom you ask, yesterday’s U.S. government workshop on the state of nonhuman primate research was either a raging success or a complete fiasco. The event, held at the National Institutes of Health (NIH) in Bethesda, Maryland, brought together dozens of scientists, veterinarians, and bioethicists to discuss how research on monkeys and related animals is contributing to human medicine and to review the welfare policies that surround this work. But observers differed widely on whether it accomplished what Congress had in mind when it told NIH to hold the event.
“It was a great showcase of the importance nonhuman primates have played and continue to play in human health,” says Anne Deschamps, a senior science policy analyst at the Federation of American Societies for Experimental Biology in Bethesda, one of several scientific organizations that signed onto a white paper released in advance of the meeting that promoted the use of these animals in biomedical research. She contends that research on these animals has been critical for our understanding of HIV and the human brain.
But the animal rights group People for the Ethical Treatment of Animals (PETA), whose lobbying efforts led to the workshop, says the meeting was supposed to determine whether monkeys and their relatives belong in laboratories in the first place. “It was an infomercial for the use of monkeys in experiments,” says PETA Senior Vice President Kathy Guillermo in Norfolk, Virginia. “It was a wasted opportunity.”